ProChon’s lead product is BioCart, a second-generation tissue regeneration implant for the treatment of joint cartilage defects and injuries.
Although back pain is common, it can be difficult for physicians to determine the exact cause of the pain using current testing methods.
NWL seeks to prevent degeneration and restore function in damaged tissue, particularly in the nervous system.
Novadaq Technologies (TSX: NDQ) develops and markets real-time fluorescence imaging technologies for use in the operating room.
The administration of the device plus the administration of as-needed anti-VEGF therapy is showing promising results.
The Danville, Calif.-based company offers CaseReader, a software solution that is designed to deliver faster, more accurate analysis of image scans.
